ATE175877T1 - Avirulenter tollwut-impfstoff - Google Patents

Avirulenter tollwut-impfstoff

Info

Publication number
ATE175877T1
ATE175877T1 AT93401843T AT93401843T ATE175877T1 AT E175877 T1 ATE175877 T1 AT E175877T1 AT 93401843 T AT93401843 T AT 93401843T AT 93401843 T AT93401843 T AT 93401843T AT E175877 T1 ATE175877 T1 AT E175877T1
Authority
AT
Austria
Prior art keywords
avirulent
rabies vaccine
avirulent rabies
vaccine
rabies
Prior art date
Application number
AT93401843T
Other languages
English (en)
Inventor
Jacqueline Benejean
Anne Flamand
Marie-Christine Tuffereau
Patrice Coulon
Florence Lafay
Original Assignee
Virbac Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Sa filed Critical Virbac Sa
Application granted granted Critical
Publication of ATE175877T1 publication Critical patent/ATE175877T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT93401843T 1992-07-20 1993-07-16 Avirulenter tollwut-impfstoff ATE175877T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9208947A FR2693655B1 (fr) 1992-07-20 1992-07-20 Vaccin antirabique avirulent.

Publications (1)

Publication Number Publication Date
ATE175877T1 true ATE175877T1 (de) 1999-02-15

Family

ID=9432070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93401843T ATE175877T1 (de) 1992-07-20 1993-07-16 Avirulenter tollwut-impfstoff

Country Status (20)

Country Link
US (1) US5853735A (de)
EP (1) EP0583998B1 (de)
AT (1) ATE175877T1 (de)
BG (1) BG61066B1 (de)
BR (1) BR9302910A (de)
CA (1) CA2100591C (de)
CZ (1) CZ283400B6 (de)
DE (1) DE69323130T2 (de)
FI (1) FI933210A7 (de)
FR (1) FR2693655B1 (de)
HR (1) HRP931065B1 (de)
HU (1) HU219266B (de)
MA (1) MA22938A1 (de)
MX (1) MX9304349A (de)
PL (1) PL172853B1 (de)
RO (1) RO112582B1 (de)
RU (1) RU2128519C1 (de)
SI (1) SI9300392A (de)
SK (1) SK280104B6 (de)
TN (1) TNSN93083A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283150T3 (es) * 1998-11-27 2007-10-16 Intervet International Bv Mutantes del virus de la rabia atenuados estables y vacunas vivas de los mismos.
IL146732A0 (en) 1999-06-03 2002-07-25 Nippon Suisan Kaisha Ltd Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
WO2001070932A2 (en) 2000-03-23 2001-09-27 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
HUP0500722A2 (hu) * 2001-07-20 2005-11-28 The University of Georgia Research Foundation, Inc@Á Attenuált veszettség vírus, a veszettség elleni vakcináláshoz és a központi idegrendszer génterápiájához egy nukleoprotein mutációval a foszforilezés helyén
ATE307606T1 (de) * 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung
EP1439856B1 (de) * 2001-10-10 2009-04-01 Thomas Jefferson University Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
EP1415665A3 (de) * 2002-11-01 2004-06-30 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. BHV5 Mutanten
DE602005021636D1 (de) 2004-07-12 2010-07-15 Univ Jefferson Zusammensetzungen mit rekombinantem tollwutvirus
EP1945780B1 (de) 2005-10-14 2015-09-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Tollwutvirusvektorsysteme sowie zusammensetzungen und verfahren dazu
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
RU2694836C1 (ru) * 2018-12-14 2019-07-17 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения антигена вируса бешенства для серологической диагностики

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent

Also Published As

Publication number Publication date
DE69323130T2 (de) 1999-06-17
BG97964A (bg) 1994-04-29
CZ283400B6 (cs) 1998-04-15
PL299739A1 (en) 1994-01-24
HUT69961A (en) 1995-09-28
SK76193A3 (en) 1994-06-08
SK280104B6 (sk) 1999-08-06
MA22938A1 (fr) 1994-04-01
FR2693655B1 (fr) 1994-10-14
FI933210A0 (fi) 1993-07-14
FI933210L (fi) 1994-01-21
MX9304349A (es) 1994-06-30
CZ140293A3 (en) 1994-02-16
SI9300392A (en) 1994-06-30
EP0583998B1 (de) 1999-01-20
RO112582B1 (ro) 1997-11-28
DE69323130D1 (de) 1999-03-04
EP0583998A1 (de) 1994-02-23
FI933210A7 (fi) 1994-01-21
FR2693655A1 (fr) 1994-01-21
RU2128519C1 (ru) 1999-04-10
BG61066B1 (bg) 1996-10-31
HRP931065A2 (en) 1995-02-28
HU219266B (en) 2001-03-28
US5853735A (en) 1998-12-29
CA2100591C (en) 2003-02-18
PL172853B1 (pl) 1997-12-31
TNSN93083A1 (fr) 1994-03-17
CA2100591A1 (en) 1994-01-21
HU9302091D0 (en) 1993-11-29
BR9302910A (pt) 1994-02-16
HRP931065B1 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
ES2074950A1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
LU91594I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3 (Infanrix - IPV)
DE69323130D1 (de) Avirulenter Tollwut-Impfstoff
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
EP0342860A3 (de) Neues Protein, Sequenze mit enthaltendem Gene, Vektoren, Verfahren zur Herstellung und Verwendung
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
DK0425082T3 (da) Vacciner
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
FR2633832B1 (fr) Vaccin antirabique avirulent
DK0721782T3 (da) Influenzavaccine indeholdende pertussistoksin
YU50393A (sh) Nova vakcina protiv besnila